NCT04943289View on ClinicalTrials.gov

Intrathecal Administration of DUOC-01 in Adults With Primary Progressive Multiple Sclerosis

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 24, 2021

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions
Primary Progressive Multiple Sclerosis
Interventions
BIOLOGICAL

DUOC-01

DUOC-01 is a population of cells expanded from donor human umbilical cord blood mononuclear cells. DUOC-01 cells are derived from CB CD14+ monocytes. DUOC-01 will be administered along with hydrocortisone via intrathecal injection.

Trial Locations (1)

27705

Duke University Medical Center, Durham

All Listed Sponsors
lead

Joanne Kurtzberg, MD

OTHER